Here Are Monday’s Best Wall Street Analyst Research Calls: Atmos Energy, Best Buy, Biogen, Capital One, Costco, Disney, Papa John’s International, Shopify, and More
The article lists Monday analyst calls and market moves. It highlights SK hynix’s Nasdaq debut, up about 12.8% to $168.01 after raising nearly $26.5B. It cites upgrades including BIIB to Buy at $235, COF to Buy at $229, and SHOP to Buy at $160, plus downgrades like BBY to Hold. Circle (CRCL) rose ~15% on OCC approval.
How this was made
The 30-second read
Why it matters
Most actionable items are analyst rating/price-target changes, while the most primary catalyst is Circle’s OCC approval and SK hynix’s record-setting debut capital raise.
Market read
Traders can use the concrete regulatory catalyst (CRCL) and the new-issue momentum (SK hynix) for near-term positioning, while analyst calls provide secondary sentiment shifts into earnings week.
What to watch
The article lacks the underlying thesis for most rating changes, so traders should verify whether the upgrade is driven by new fundamentals or just valuation/expectations.
Background
The piece is a daily roundup of analyst research calls plus a market wrap, highlighting Friday’s SK hynix Nasdaq debut and a crypto-stock rally tied to Circle’s OCC approval.
Ticker impact
Circle Internet Group jumped nearly 15% after OCC approval to establish a national trust bank.
Near-term upside bias with potential follow-through as traders price in expanded banking capabilities.
The text ties the move directly to a specific regulator approval (OCC) and quantifies the stock reaction.
Capital One was raised to Buy from Hold at HSBC with a $229 target price.
Moderate positive drift possible into the next sessions, subject to broader rates/credit sentiment.
This is a clear, same-day analyst action with a stated target, but it is not a primary company disclosure like earnings or guidance.
Biogen was upgraded to Buy from Hold at Truist with a $235 target price.
Short-term support likely, but magnitude depends on how the market already priced the stock.
The article gives the upgrade and target, but no new company-specific operational datapoint.
Atmos Energy was initiated with an Overweight rating at Wells Fargo and a $200 target price.
Mild positive bias over days to weeks if the thesis resonates with rate and demand expectations.
Initiation is actionable, but the article provides no thesis details beyond rating and target.
Shopify was upgraded to Buy from Hold at Jefferies, moving its target to $160 from $140.
Potential upside follow-through if broader risk appetite holds.
The catalyst is explicit (upgrade and target change), but the article lacks new Shopify-specific fundamentals.
Walt Disney was started with a Buy rating at Benchmark with a $115 target price objective.
Limited to moderate near-term support depending on market expectations for Disney catalysts.
The article states the initiation and target but provides no supporting new information.
Best Buy was cut to Hold from Buy at Loop Capital, with an unchanged $82 target.
Slight downside bias or underperformance risk near-term.
The directionality is clear (downgrade), but the unchanged target suggests limited fundamental change.
Kymera Therapeutics was cut to Sector Perform from Outperform at RBC Capital, with target raised to $115 from $106.
Likely volatility without a clear directional edge from this single note.
The article provides the rating/target changes but no thesis explaining the downgrade.
Market effects
Memory/AI sentiment is reinforced by SK hynix’s debut strength; crypto banking optionality is reinforced by CRCL’s OCC approval.
U.S. listing activity and foreign issuer demand are highlighted via SK hynix’s record raise.
Regulatory progress in crypto-adjacent banking and ongoing Middle East risk are framed as cross-asset drivers (equities, oil, rates).
Counterpoint
Analyst upgrades and targets may already be partially priced, so follow-through could fade if broader macro (rates, Iran risk) turns risk-off.
Key entities
- companySK hynix
Nasdaq debut with a large foreign equity sale and a strong first-day gain.
- companyCircle Internet Group
OCC approval to establish a national trust bank, driving a sharp stock jump.
- companyCapital One
HSBC upgrade to Buy with a $229 target.
- companyBiogen
Truist upgrade to Buy with a $235 target.
